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ABSTRACT 
 
De Novo Asymmetric Synthesis of Digitoxin Based Carbohydrate Libraries 
 
Wenjun Xin 
 
 
The enantioselective syntheses of digitoxigen 2,6-dideoxy-β-L-ribo-hexopyranoside, 
its analogues and digitoxin monosaccharide analogues have been achieved. Key to 
this approach is the iterative application of the palladium-catalyzed glycosylation 
reaction, reductive 1,3-transposition and diastereoselective dihydroxylation. 
Anticancer tests showed that these analogues have even better anticancer activities.   
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CHAPTER I 
 
Asymmetric Synthesis of Digitoxin Sugar Analogues 
 
1.1 Introduction 
 
Digitoxin (1) (Figure 1) is a cardiac glycoside which can be extracted from the 
leaves of Digitalis purpurea (purple foxglove). It has long been used to slow the heart 
rate while increasing the contractility of the heart muscle (inotropic activity). It has been 
widely prescribed for congestive heart failure and cardiac arrhythmia for over 200 years. 
Oligosaccharides bearing deoxysugars have played a pivotal role in many 
pharmacologically important antibiotics, vaccines and antitumor agents.1 Digitoxin has 
also been shown to possess potential anticancer activities.2 The natural product digitoxin 
contains three D digitose sugars. Structurally, digitoxin is the combination of two natural 
products, the aglycon digitoxigenin (2)3 and the trisaccharide digoxose (3).4  
 
Figure 1.  Digitoxin, digitoxigenin and digoxose. 
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1.2 Previous approaches to digitoxin 
 
There have been two syntheses of digitoxin from the aglycone, a carbohydrate 
approach by Wiesner (~20 steps from a protected 2-deoxy sugar) and a de novo approach 
by McDonald (20 steps from TMS-acetylene).5 There have been 8 syntheses of 
digitoxigenin.6
The first synthesis of digitoxin from digitoxigenin was accomplished by 
Wiesner’s group (Scheme 1). The stereochemistry of the digitoxin glycoside bond was 
controlled by a 1,3-participation of PMBz ester (4). The PMBz ester (4) was derived from 
a 1,3-participation of N-methylurethane (5) which was derived from bromide (6) in 7 
steps. In turn, bromide (6) was prepared from methyl α-D-glucoside.  
Scheme 1. Retrosynthetic analysis of Wiesner’s synthesis. 
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McDonald’s synthesis (Scheme 2) achieved the product digitoxin by the acid 
catalyzed glycosylation of digitoxigenin and trisaccharide glycal (7). The trisaccharide 
glycal (7) was derived from 6-deoxy-D-riboglycal (8) and alkynyl alcohol (9) through an 
acid catalyzed glycosylation. Furthermore, these two compounds were derived from 
alkynyl enone (10) in seven and five steps, respectively.  
Scheme 2. Retrosynthetic analysis of McDonald’s synthesis. 
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1.3 O’Doherty’s synthesis of digitoxin 
O’Doherty’s group also prepared digitoxin via a de novo strategy, which could 
also be used to prepare various digitoxin analogues (Scheme 3).7  Due to the missing 
stereo-control element at the 2-position, it is particularly difficult to synthesize β-2-
deoxy-glycosides. They successfully addressed the 2-deoxy-β-glycosides using a 
diastereoselective palladium-catalyzed glycosylation reaction. Digitoxin was derived 
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from digitoxin disaccharide (11), which was produced from a corresponding digitoxin 
monosaccharide. This digitoxin monosaccharide was prepared from digitoxigenin and 
Boc-pyranone (13β) via a palladium-catalyzed glycosylation reaction. Boc-pyranone 
(13β) was derived from the commercially available compound acylfuran (14). Comparing 
with the previous approaches, the O’Doherty’s approach is a more efficient route in terms 
of number of steps and stereocontrol. In addition, this route is more amenable. 
            
Scheme 3. Retrosynthetic analysis of O’Doherty’s synthesis. 
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1.4 Total synthesis of digitoxigen 2,6-β-L-ribo-hexopyranoside and its analogues 
1.4.1 Background 
Previously, O’Doherty’s group successfully synthesized and tested the natural 
compound digitoxin and its mono- and di-saccharide analogues as antitumor agents. The 
biological tests of these compounds from NCI (National Cancer Institute) showed that in 
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general the digitoxin monosaccharide is more active than digitoxin or the digitoxin 
disaccharide in cancer cell cytoxicity (Figure 2).8 To further understand this phenomenon, 
we were interested in synthesizing several unnatural L-sugar digitoxin analogues (figure 
3) with the particular goal of finding the most active anticancer agent. 
Figure 2.  Anticancer tests results of digitoxin mono-, di- and tri-saccharide. 
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Figure 3. The L-sugar digitoxin mono-, di- and tri-saccharide. 
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1.4.2 Retrosynthetic analysis 
           A similar approach was planed to synthesize these L-sugar digitoxin 
diastereomeric analogues (Scheme 4). The final product, L-sugar digitoxin trisaccharide 
could be derived from L-sugar digitoxin disaccharide through a palladium-catalyzed 
glycosylation reaction. The disaccharide could also be prepared from the L-sugar 
digitoxin monosaccharide via a palladium-catalyzed glycosylation reaction. The 
monosaccharide could be produced from the palladium-catalyzed glycosylation of 
digitoxigenin and L-Boc-pyranone (18β). From previous work, it was known that the 
Boc-pyranone (18β) could be derived from acylfuran. 
 
 
 6
Scheme 4. Retrosynthetic analysis of L-sugar digitoxin. 
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1.4.3 Synthesis of Boc-pyranones 
According to the O’Doherty group’s previous approach, acylfuran (14) could be 
enantioselectively reduced (Noyori (S,S), >95% ee)9 to furan alcohol (19) and converted 
into the L-sugar pyranone (20) and then diastereoselectively acylated into the α-Boc-
pyranone (18α) and β-Boc-pyranone (18β).10 Alternatively,  using the Noyori (R,R) 
catalyst would provide the enantiomeric furan alcohol (21) and similarly lead to the two 
D-sugar diastereometers (13α) and (13β). When the Boc-protection was performed at -78 
ºC, the α:β ratio is 3:1. When the Boc-protection was performed at elevated temperature 
((Boc)2O/NaOAc in benzene at 80 ºC), a switch in the diastereoselectivity occurred 
(Scheme 5). The ratio of β-pyranone to α-pyranone at these higher temperatures could be 
as high as 1.3:1.  
 7
Scheme 5. Enantio-and diastereoselective pyranone synthesis. 
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1.4.4 Synthesis of digitoxigen 2,6-dideoxy-β-L-ribo-hexopyranoside      
Starting from β-Boc-pyranone (18β), a palladium-catalyzed glycosylation reaction 
was performed between digitoxigenin (2) and Boc-pyranone (18β) which gave pyranone 
(23) in 85% yield. Pyranone (23) was then reduced with NaBH4 to obtain allylic alcohol 
(24) in 81% yield. The reductive rearrangement gave olefin (25) in 98% yield. The 
dihydroxylation of olefin (25) achieved the L-sugar digitoxin monosaccharide (15) in 
93% yield (Scheme 6). 
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Scheme 6. Synthesis of digitoxigen 2,6-dideoxy-β-L-ribo-hexopyranoside.      
OBocO
O
Pd(0)/PPh3
85%
NaBH4
 NBSH, PPh3
DEAD
 98%
OsO4/NMO
93%
O O
Me
OH
H
H
Me
H
HO
digitoxigenin
O O
Me
OH
H
H
Me
H
O
O O
Me
OH
H
H
Me
H
O
81%
CeCl3
OHO
O
O
Me
OH
H
H
Me
HO
OH
digitoxigen 2,6-dideoxy-β-L-ribo-hexopyranoside
O
O
O
Me
OH
H
H
Me
HO
(2)
(23)
(24) (25)
(18β)
(15)
O
O
O
HO
 
 
1.4.5 Synthesis of digitoxigen 2,6-dideoxy-β-L-ribo-hexopyranoside analogues 
From the L-sugar digitoxin monosaccharide (15), digitoxigen 2,6-dideoxy-β-L-
gluco-hexopyranoside (26) was synthesized (Figure 4). 
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Figure 4. Digitoxin monosaccharide sugar analogues.         
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Mitsunobu reaction11 of the L-sugar digitoxin monosaccharide (15) gave the C-3 
inverted ester (30) in 85% yield. Hydrolysis of (30) with MeOH/Et3N provided the 
diastereomeric monosaccharide digitoxigen 2,6-dideoxy-β-L-gluco-hexopyranoside (26) 
in good yield (Scheme 7). 
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Scheme 7. Synthesis of digitoxigen 2,6-dideoxy-β-L-gluco-hexopyranoside.       
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The palladium-catalyzed glycosylation reaction of digitoxigenin (2) and α-Boc-
pyranone (18α) gave pyranone (31) in good yield. Then pyranone (31) was reduced with 
NaBH4 to obtain analogue digitoxigen 2,3-dideoxy-α-L-rhamno-hexopyranoside (27) in 
83% yield. Dihydroxylation of (27) gave the rhamno analogue (28). Reductive 
rearrangement of (27) gave C-2/C-3 dideoxy analogue (29) in 96% yield (Scheme 8). 
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Scheme 8. Synthesis of digitoxigen rhamno analogues. 
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1.4.6 Anticancer tests results of digitoxin monosaccharide sugar analogues         
After having successfully synthesized several L-sugar digitoxin monosaccharide 
analogues, these compounds were sent for anticancer testing.12 Tests results showed that 
these analogues have excellent anticancer activities. In fact, analogue (28) shows the best 
anticancer activity comparing with other analogues. For instance, (28) is 13.5 times more 
active than digitoxin in killing HT-29 cancer cell lines. Analogues (15), (26), (29) also 
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show much better activities comparing with digitoxin although the difference isn’t as 
great (Figure 5). 
Figure 5. Anticancer tests results of digitoxin monosaccharide sugar analogues.  
 
 
 
 
 
 
0.000
0.050
0.100
0.150
0.200
0.250
0.300
0.350
0.400
0.450
0.500
HT-29 NCI-H460 NCI-ADR
RES
NCI-ADR
RES
Cell Lines
GI
50
 (
nM
)
WX-027
WX-033
WX-053
WX-055
WX-057
Dig
 
 
 
WX-027: (15)      WX-033: (26)      WX-053: (27)       WX-055: (29)       WX-057: (28) 
Dig: digitoxin (1) 
 
1.4.7 Synthesis of digitoxigen 2,6-dideoxy-α-D-ribo-hexopyranoside analogues 
Starting with Boc-pyraone (13α), a number of D-sugar digitoxin monosaccharide 
analogues have been achieved (Scheme 9). The palladium-catalyzed glycosylation 
reaction of digitoxigenin (2) and α-Boc-pyranone (13α) gave pyranone (32) in good 
yield. Then pyranone (32) was reduced with NaBH4 to obtain the digitoxigen 2,3-
dideoxy-α-D-rhamno-hexopyranoside (33) in 90% yield. Reductive rearrangement of 
(33) gave the dideoxy analogue (34) in 95% yield.  
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Scheme 9. Synthesis of digitoxigen 2,6-dideoxy-α-D-ribo-hexopyranoside analogues. 
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1.4.8 Synthetic effort towards the L-β-glycoside of desacetoxy-oleandrin 
Oleandrin (35) (Figure 6) is another cardiac glycoside which can be extracted 
from the leaves of one of the very poisonous plants oleander. The structures of digitoxin 
monosaccharide and β-oleandrin are very similar, with the addition of a C-16 acetoxy 
group and a C-3 methylated D-2-deoxy glucose sugar. We are interested in synthesizing 
an L-sugar β-desacetoxy-oleandrin from digitoxin monosaccharide and comparing their 
anticancer activities. 
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Figure 6.  Oleandrin, the L-β-glycoside of desacetoxy-oleandrin and digitoxigen 2,6-   
                 dideoxy-β-L-ribo-hexopyranoside. 
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The synthesis of digitoxigen 2,6-dideoxy-β-L-gluco-hexopyranoside (26) has 
already been achieved in good yield. Thus the synthesis of analogue (36) began with the 
direct methylation of (26)13 to selectively prepare the L-β-glycoside of desacetoxy-
oleandrin (36) (Scheme 10). 
Scheme 10. Synthetic effort towards the L-β-glycoside of desacetoxy-oleandrin. 
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digitoxigen 2,6-dideoxy-β-L-gluco-hexopyranoside (26) L-β-glycoside desacetoxy-oleandrin (36)
 
However, this methylation reaction was not very selective. The highest yield was 
25% by treating β-2,6-dideoxy-L-gluco-digitoxin-monosaccharide (26) with MeI and 
Ag2O, which yielded a mixture of regioisomers. 
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1.4.9 Conclusion 
A highly stereoselective route to anticancer compounds digitoxin and its 
analogues has been developed. This approach has been successfully applied to the 
synthesis of L-sugar digitoxin monosaccharide and several analogues. Anticancer tests 
showed that these analogues have excellent anticancer activities. 
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Chapter II 
Experimental Section 
General Methods and Materials.   
1H and 13C NMR spectra were recorded on Jeol (270 MHz) and Varian VXR-600 (600 
MHz) spectrometers. Chemical shifts are reported relative to internal tetramethylsilane (δ 
0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H NMR and CDCl3 (δ 77.0 ppm) for 13C NMR.  
Infrared (IR) spectra were obtained on a Prospect MIDAC FT-IR spectrometer.  Optical 
rotations were measured with a Jasco DIP-370 digital polarimeter in the solvent specified.  
Melting points were determined with Electrothermal Mel-Temp apparatus and are 
uncorrected.  Flash column chromatography was performed on ICN reagent 60 (60-200 
mesh) silica gel.  Analytical thin-layer chromatography was performed with precoated 
glass-backed plates (Whatman K6F 60Å, F254) and visualized by quenching of 
fluorescence and by charring after treatment with p-anisaldehyde or phosphomolybdic 
acid or potassium permanganate stain.  Rf values are obtained by elution in the stated 
solvent ratios (v/v).  Ether, THF, methylene chloride and triethylamine were dried by 
passing through activated alumina (8 x 14 meshes) column with argon gas pressure. 
Commercial reagents were used without purification unless otherwise noted. Melting 
points are uncorrected.  Air and/or moisture-sensitive reactions were carried out under an 
atmosphere of argon/nitrogen using oven/flamed-dried glassware and standard 
syringe/septa techniques. 
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(S)-1-(2-Furyl)-ethanol (19):14
O
OH
 
To a 25 ml flask was added furan ketone 14 (22.0 g, 7.27 mmol), CH2Cl2 (101.8 mL), 
formic acid/triethylamine (1:1, 110.6 mL) and Noyori asymmetric transfer hydrogenation 
catalyst (R)-Ru(η6-mesitylene)-(S,S)-TsDPEN (582 mg, 0.5 mol%). The resulting 
solution was stirred at room temperature for 24 h. The reaction mixture was diluted with 
water (200 mL) and extracted with EtOAc (3 x 500 ml). The combined organic layers 
were washed with saturated NaHCO3, dried over Na2SO4, and concentrated under 
reduced pressure. The crude  product  was  purified  by  silica  gel  flash  chromatography  
eluting  with 30% ether/hexanes to give furan alcohol 19 (21.3 g, 192 mmol, 96%): 
colorless oil; Rf (30% EtOAc/hexanes) = 0.41; [α]25D = + 21 (c = 1.0, CH2Cl2); IR (thin 
film, cm-1) 3360, 2980, 2935, 1668, 1505, 1467, 1370, 1229, 1149, 1007, 877, 734; 1H 
NMR  (600 MHz CDCl3) δ 7.30 (d, J = 1.8, 1H), 6.26 (dd, J = 3.0, 1.8 Hz, 1H),  6.15 (d, 
J = 3.0, 1H), 4.78 (dq, J = 6.6, 6.6 Hz, 1H), 3.11 (s, 1H), 1.46 (d, J = 6.6 Hz, 3H); 13C 
NMR (150 MHz, CDCl3) δ157.7, 141.6, 109.9, 104.9, 63.3, 21.1.  
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(2S)-6-Hydroxy-2-methyl-2H-Pyran-3 (6H)-one (20):14
OHO
O
 
Furan alcohol 19 (21.0 g, 189 mmol), THF (466 mL), and H2O (155 mL) were added to a 
round bottom flask and cooled to 0 oC. Solid NaHCO3 (33.4 g, 378 mmol), NaOAc•3H2O 
(25.6 g, 189 mmol), and NBS (33.2 g, 189 mmol) were added to the solution and the 
mixture was stirred for 1 h at 0 oC. The reaction was quenched with saturated  NaHCO3 
(400 mL), extracted (3 x 400 mL) with Et2O, dried (Na2SO4), concentrated under reduced 
pressure and purified by silica gel chromatography eluting with 25% EtOAc/hexanes to 
give pyranone 20 (21.8 g, 172 mmol, 91%): Rf (60% EtOAc/hexanes) = 0.29; [α]25D = + 
44 (c = 1.0, CH2Cl2); IR (thin film, cm-1) 3381, 2988, 2942, 1692, 1447, 1373, 1232, 
1021, 937; 1H NMR (600 MHz, CDCl3) major isomer δ 6.82 (dd, J = 10.2, 3.0 Hz, 1H), 
5.96 (d, J = 10.2, 1H), 5.48 (d, J = 3.0 Hz, 1H), 3.99 (q, J = 7.2 Hz, 1H), 1.23 (d, J = 7.2 
Hz, 3H); 13C NMR (150 MHz, CDCl3) major isomer δ 197.6, 145.3, 126.6, 87.2, 74.8, 
15.1.  
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(2S, 6S)-tert-butyl -5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yl carbonate (18):14
OBocO
O
 
A benzene solution (288 mL) of pyronone alcohol 20 (15.1 g, 118 mmol) was added 
sodium acetate (10.7 g, 130 mmol) and (Boc)2O (38.7 g, 117 mmol). The mixture was 
heated to 80 oC for 1 h. Then it was cooled down and quenched with 200 mL ice cold 
saturated NaHCO3, extracted with Et2O (3 x 500 mL), dried (Na2SO4), and concentrated 
under reduced pressure. The  crude  product  was  purified  using  silica  gel  flash 
chromatography eluting with 6% EtOAc/hexanes to give 22.0 g (96.8 mmol, 82%) of two 
diastereomers of Boc-protected pyranone 18α and 18β in 1:1.3: Rf (20% Et2O/hexane) = 
0.58; [α]25D = + 98 (c = 1.0, CH2Cl2); IR (thin film, cm-1) 2984, 2942, 1752, 1703, 1371, 
1273, 1254, 1153, 938, 838; 1H NMR (600 MHz, CDCl3) δ 6.78 (dd, J = 10.2, 3.6 Hz, 
1H), 6.22 (d, J = 3.6 Hz, 1H), 6.09 (d, J = 10.2 Hz, 1H), 4.53 (q, J = 6.6 Hz, 1H), 1.40 (s, 
9H), 1.28 (d, J = 6.6 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 195.5, 151.7, 140.9, 128.2, 
89.1, 83.3, 72.0, 27.5, 15.1; ClHRMS Calculated for [C11H16O5Na+]: 251.0890, Found: 
251.0883.  
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(2S, 6S)-2-Digitoxigenoxy-6-methyl-2H-pyran-3(6H)-one (23): 
O
O O
Me
OH
H
H
Me
H
O
O
 
A CH2Cl2/THF solution (19 mL, 4:1 V/V) of Boc-pyranone 18β (1.29 g, 5.65 mmol) and 
digitoxigenin (3.17 g, 8.48 mmol) was cooled to 0 oC. A CH2Cl2 (2.5 mL) solution of 
Pd2(DBA)3•CHCl3 (170 mg, 2.5 mol%) and PPh3 (171 mg, 10 mol%) was added to the 
reaction mixture at 0 oC. The reaction mixture was stirred at 0 oC for 8 hours and was 
quenched with 20 mL of satd. aq NaHCO3, extracted (3 x 50 mL) with Et2O, dried 
(Na2SO4), and concentrated under reduced pressure. The crude product was purified 
using silica gel flash chromatography eluting with 40% EtOAc/hexanes to give 23 (2.32 g, 
4.80 mmol, 85%) as a white solid: Rf (40% EtOAc/hexanes) = 0.17; mp: 211-212 oC; 
[α]25D = + 5.28 (c = 1.0, CHCl3); IR (thin film, cm-1) 3505, 2938, 2875, 2376, 2311, 1780, 
1741, 1698, 1620, 1448, 1374, 1164, 1144, 1053, 1028, 730; 1H NMR (600 MHz, CDCl3) 
δ 6.87 (dd, J = 10.4, 1.8 Hz, 1H), 6.12 (dd, J = 10.2, 1.2 Hz, 1H), 5.87 (m, 1H), 5.39 (dd, 
J = 2.4, 1.8 Hz, 1H), 4.99 (dd, J = 18.0, 1.8 Hz, 1H), 4.81 (dd, J = 18.0, 1.8 Hz, 1H), 4.18 
(m, 2H), 2.78 (dd, J = 9.6, 6.0 Hz, 1H), 2.20-2.09 (m, 3H), 1.45 (d, J = 6.6 Hz, 3H), 1.92-
1.16 (m, 18H), 0.95 (s, 3H), 0.88 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 197.0, 174.4, 
174.3, 147.7, 128.2, 117.8, 93.9, 85.6, 75.2, 73.4, 73.3, 50.9, 49.6, 41.9, 40.0, 36.3, 35.8, 
35.2, 33.2, 32.0, 30.0, 26.9, 26.4, 24.4, 23.7, 21.3, 21.2, 17.0, 15.8; ESIHRMS Calcd for 
[C29H40O6Na+]: 507.2717,  Found 507.2722.  
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(2S, 6S)-2-(Digitoxigenoxy)-2,5-dihydro-6-methyl-2H-pyran-5-ol (24): 
O
O O
Me
OH
H
H
Me
H
O
HO
 
A CH2Cl2 (9.4 mL) solution of enone 23 (2.32 g, 4.80 mmol) and CeCl3 in MeOH 
solution (0.4 M, 9.4 mL) was cooled to -78 oC. NaBH4 (162 mg, 4.80 mmol) was added 
and the reaction mixture was stirred at -78 oC for 3 h. The reaction mixture was diluted 
with ether (60 mL) and was quenched with 30 mL of satd. aq NaHCO3, extracted (3 x 60 
mL) with Et2O, dried (Na2SO4), and concentrated under reduced pressure. The crude 
product was purified using silica gel flash chromatography eluting with 55% 
EtOAc/hexanes to give allylic alcohols 24a/b (1.89 g, 3.88 mmol, 81%) as a white solid 
(diastereometric ratio 24a:24b = 1.5:1, inseparable by silica gel chromatography): Rf 
(60% EtOAc/hexanes) = 0.22; IR (thin film, cm-1) 3449, 2934, 2871, 1779, 1737, 1619, 
1448, 1380, 1320, 1169, 1136, 1051, 1026, 1006, 961, 751; 1H NMR (600 MHz, CDCl3) 
24a δ 6.12 (ddd, J = 10.2, 4.8, 1.2 Hz, 1H), 5.86 (m, 1H), 5.79 (d, J = 10.2 Hz, 1H), 5.07 
(m, 1H), 4.97 (dd, J = 18.0, 1.2 Hz, 1H), 4.80 (dd, J = 18.0, 1.8 Hz, 1H), 4.12 (dd, J = 4.2, 
1.8 Hz, 1H), 4.11(s, 1H), 3.70 (qd, J = 6.6, 2.4Hz, 1H), 3.60 (br, 1H), 2.77 (dd, J = 9.6, 
6.0 Hz, 1H), 2.25-2.05 (m, 3H), 1.30 (d, J = 6.0 Hz, 3H), 1.80-1.05 (m, 18H), 0.93 (s, 
3H), 0.86 (s, 3H);  24b δ 5.91(ddd, J = 10.2, 2.4, 2.4 Hz, 1H), 5.86 (m, 1H), 5.74 (ddd, J 
= 10.2, 1.2, 1.2 Hz, 1H), 5.13 (ddd, J = 1.8, 1.8, 1.8 Hz, 1H), 4.98 (dd, J = 18.0, 1.2 Hz, 
1H), 4.80 (dd, J = 18.0, 1.2 Hz, 1H), 4.09 (m, 1H), 4.11 (s, 1H), 3.91 (br, 1H), 3.59(dq, J 
= 6.6, 6.6 Hz, 1H), 2.77 (dd, J = 9.6, 6.0 Hz, 1H), 2.25-2.05 (m, 3H), 1.33 (d, J = 6.0 Hz, 
 22
3H), 1.80-1.05 (m, 18H), 0.94 (s, 3H), 0.87 (s, 3H); 13C NMR (150 MHz, CDCl3) 24a δ 
174.64, 174.60, 131.8, 131.0, 117.6, 96.0, 85.3, 74.3, 73.1, 71.4, 64.6, 50.9, 49.6, 41.8, 
40.0, 36.4, 35.7, 35.1, 33.0, 32.1, 29.9, 26.9 (2C), 26.4, 23.6, 21.2, 21.1, 16.7, 15.7; 24b δ 
174.67, 174.60, 131.3, 129.8, 117.6, 94.8, 85.4, 73.4, 73.1, 72.3, 68.5, 50.9, 49.6, 41.8, 
40.0, 36.3, 35.7, 35.1, 33.1, 32.0, 29.9, 26.8 (2C), 26.6, 23.6, 21.2, 21.1, 18.3, 15.7; 
ESIHRMS Calcd for [C29H42O6Na+]: 509.2879,  Found 509.2879.  
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(2S, 6S)-2-(Digitoxigenoxy)-3,6-dihydro-6-methyl-2H-pyran (25): 
O
O O
Me
OH
H
H
Me
H
O
 
A flask was charged with dry N-methyl morpholine (NMM) 5.76 mL, triphenyl 
phosphine (3.36 g, 12.8 mmol) and was cooled to -30 oC under Ar atmosphere. 
Diethylazodicarboxylate (1.83 mL, 11.7 mmol) was added and the reaction was stirred 
for 5 min, allylic alcohol 24a/b (1.89 g, 3.88 mmol) was added in a 1 M solution of 
NMM and the reaction mixture was stirred for 10 min, followed by addition of o-
nitrobenzenesulfonyl hydrazide (NBSH) (2.36 g, 12.8 mmol). The reaction was stirred at 
-30 oC for 6h and was monitored by TLC, upon consumption of starting material, warm 
up to room temperature and stirred for another 1 h. The reaction mixture was diluted with 
ether (60 mL) and was quenched with 60 mL of satd. aq NaHCO3, extracted (3 x 60 mL) 
with Et2O, dried (Na2SO4), and concentrated under reduced pressure. The crude product 
was purified using silica gel flash chromatography eluting with 25% EtOAc/hexanes to 
give product 25 (1.80 g, 3.82 mmol, 98%) as a white solid:  Rf (30% EtOAc/hexanes) = 
0.20; mp: 157-158 oC; [α]25D = +23.3 (c = 1.1, CHCl3); IR (thin film, cm-1) 3301, 2933, 
2871, 1778, 1742, 1620, 1447, 1378, 1221, 1157, 1133, 1097, 1065, 1024, 974, 909, 782. 
1H NMR (600 MHz, CDCl3)  δ 5.86 (m, 1H), 5.66 (dddd, J = 10.2, 4.8, 2.4, 2.4 Hz, 1H), 
5.55 (dddd, J = 10.2, 2.4, 1.2, 1.2 Hz, 1H), 4.99 (dd, J = 18.0, 1.2 Hz, 1H), 4.80 (dd, J = 
18.0, 1.2 Hz, 1H), 4.70 (dd, J = 8.4, 3.0 Hz, 1H), 4.06 (m, 1H), 4.29 (m, 1H), 2.76 (m, 
1H), 2.24-2.04 (m, 4H), 1.90-1.08 (m, 19H), 1.24 (d, J = 6.0 Hz, 3H), 0.92 (s, 3H), 0.86 
 24
(s, 3H); 13C NMR (150 MHz, CDCl3) δ 174.6, 174.5, 131.1, 123.0, 117.6, 96.7, 85.6, 
73.4, 72.1, 70.7, 50.9, 49.6, 41.9, 40.1, 36.3, 35.7, 35.2, 33.1, 31.6, 30.2, 29.8, 26.9, 26.7, 
26.6, 23.6, 21.4, 21.1, 21.0, 15.8;  ESIHRMS Calcd for [C29H42O5Na+]: 493.2929, Found 
493.2930.  
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Digitoxigen 2,6-dideoxy-β-L-ribo-hexopyranoside (15):  
O
O O
Me
OH
H
H
Me
H
O
OH
HO
 
To a t-BuOH/acetone (4 mL) solution of olefin 25 (1.80 g, 3.82 mmol) at 0 oC was added 
a solution of (50% w/v) of N-methyl morpholine N-oxide/water (2.4 mL). Crystalline 
OsO4 (9.6 mg, 1 mol %) was added and the reaction was stirred for 4 h. The reaction was 
quenched with adding EtOAc and satd. NaHCO3. The organic layer was separated and 
concentrated. It was purified by a silica gel column using 90% EtOAc/hexanes. Pure 
fractions were combined, concentrated, and crystallized from acetone/hexanes to afford 
alcohol 15 (2.07 g, 3.55 mmol, 93%) as a white solid: Rf (EtOAc) = 0.42; [α]25D = +30.2  
(c = 1.0, MeOH); mp: 188-189 oC; IR (thin film, cm-1) 3440, 2934, 2856, 2193, 1736, 
1619, 1448, 1380, 1160, 1134, 1065, 1026,1002, 949, 906, 824; 1H NMR (600 MHz, 
CDCl3) δ 5.86 (m, 1H), 4.98 (d, J = 18.0 Hz, 1H), 4.86 (dd, J = 9.0, 1.8 Hz, 1H), 4.80 (d, 
J = 18.0 Hz, 1H), 4.11 (ddd, J = 3.0, 3.0, 3.0 Hz, 1H), 4.02 (m, 1H), 3.71 (dq, J = 9.0, 6.0 
Hz, 1H), 3.32 (m, 1H), 2.77 (m, 1H), 2.56 (s, 1H), 2.39 (s, 1H), 2.20-2.00 (m, 4H), 1.29 
(d, J = 6.0 Hz, 3H), 1.90-1.10 (m, 19H), 0.91 (s, 3H), 0.86 (s, 3H); 13C NMR (150 MHz, 
CDCl3) δ 175.0, 174.9, 117.8, 95.6, 85.8, 73.8, 73.2, 72.9, 69.5, 68.5, 51.2, 49.8, 42.0, 
40.2, 38.5, 36.5, 35.9, 35.4, 33.4, 32.3, 30.2, 27.1, 26.6, 24.6, 23.8, 21.5, 21.4, 18.4, 16.0; 
ESIHRMS Calcd for [C29H44O7Na+]: 527.2979, Found 527.2985.  
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(2S, 6S)-2-methyl-3-hydroxy-6-Digitoxigenoxy-2H-pyran-4-nitrobenzoate (30): 
Me
Me
O
O
O
OH
H
H
HO
OPNBz
HO
 
A THF (0.6 mL) solution of diol 15 (50 mg, 0.1 mmol) at 0 oC was added PPh3 (41 mg, 
0.16 mmol) and p-nitrobenzoic acid (40 mg, 0.2 mmol), DEAD (27.5 mg, 0.16 mmol) in 
THF (0.2 mL) was added drop wise. The reaction mixture was warmed up to room 
temperature and stirred for 5 h. The reaction mixture was diluted with 5 mL EtOAc and 
quenched with 4 mL of satd. NaHCO3, extracted with Et2O (3 x 5 mL), dried (Na2SO4), 
and concentrated under reduced pressure. The crude product was purified using silica gel 
flash chromatography eluting with 60% EtOAc/hexanes to afford 30 (56 mg, 0.85 mmol, 
85%) as a white solid: Rf (EtOAc) = 0.75; [α]25D = +8.68 (c =0.5, CHCl3); mp: 188-189 
oC; IR (thin film, cm-1) 3484, 2931, 2364, 2197, 2168, 2038, 1730, 1529, 1448, 1346, 
1278, 1103, 1069, 1026, 989, 908; 1H NMR (600 MHz, CDCl3) δ 8.25 (m, 4H), 5.86 (m, 
1H), 5.10 (m, 1H), 4.98 (d, J = 18.0 Hz, 1H), 4.80 (d, J = 18.0 Hz, 1H), 4.66 (dd, J = 8.4, 
1.2 Hz, 1H), 4.07 (m, 1H), 3.48 (m, 1H), 3.40 (dq, J = 9.0, 6.0 Hz, 1H), 2.77 (m, 1H), 
2.39 (dd, J = 12.0, 6.0 Hz, 1H), 2.20-2.05 (m, 4H), 1.39 (d, J = 6.0 Hz, 3H), 1.90-1.10 (m, 
19H), 0.93 (s, 1H), 0.91 (s, 3H), 0.86 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 174.5, 
174.45, 131.1, 123.0, 117.7, 96.7 (2C), 85.6, 73.4, 73.1, 72.1, 70.7, 62.2 (2C), 51.0, 50.9, 
49.6, 41.9, 40.1, 36.3, 35.7, 35.2, 33.2, 32.2, 31.6, 30.0, 26.9, 26.4, 24.3, 23.6, 21.3, 21.2, 
21.1, 15.8, 14.4 (2C); ESIHRMS Calcd for [C36H47NO10Na+]: 653.7591, Found 653.7591.  
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Digitoxigen 2,6-dideoxy-β-L-gluco-hexopyranoside (26): 
Me
Me
O
O
O
OH
H
H
HO
OH
HO
 
A MeOH (0.2 mL) solution of 30 (28 mg, 42 µmol) at room temperature was added Et3N 
(12.6 mg, 126 µmol) and the reaction mixture was stirred for 2 h. The reaction mixture 
was diluted with 5 mL EtOAc and quenched with 4 mL of Satd. NaHCO3, extracted (3x 5 
mL) with Et2O, dried (Na2SO4), and concentrated under reduced pressure. It was purified 
by a silica gel column using 90% EtOAc/hexanes. Pure fractions were combined, 
concentrated, and crystallized from acetone/hexanes to afford 26 (20.1 mg, 40 µmol, 95%) 
as a white solid: Rf (EtOAc) = 0.42; [α]25D = +30.2  (c =1.0, MeOH); mp: 255-256 oC; IR 
(thin film, cm-1) 3453, 2940, 2856, 2173, 1969, 1775, 1742, 1623, 1449, 1454, 1378, 
1160, 1067, 1024, 951, 822; 1H NMR (600 MHz, CDCl3) δ 5.86 (m, 1H), 4.98 (dd, J = 
18.0, 1.8 Hz, 1H), 4.80 (dd, J = 18.0, 1.8 Hz, 1H), 4.53 (dd, J = 9.6, 1.8 Hz, 1H), 4.02 (m, 
1H), 3.58 (dq, J = 9.0, 6.0 Hz, 1H), 3.24 (m, 1H), 3.09 (m, 1H), 2.77 (m, 1H), 2.33 (s, 
1H), 2.20-2.00 (m, 4H), 1.26 (d, J = 6.0 Hz, 3H), 1.90-1.10 (m, 21H), 0.92 (s, 3H), 0.86 
(s, 3H); 13C NMR (150 MHz, CDCl3) δ 174.65, 174.61, 117.6, 97.3, 85.4, 77.5, 73.5, 
72.9, 71.8, 71.6, 50.9, 49.6, 41.8, 40.0, 39.5, 36.2, 35.7, 35.1, 33.1, 32.0, 29.9, 26.9, 26.4, 
24.4, 23.6, 21.2, 21.1, 17.8, 15.8; ESIHRMS Calcd for [C29H44O7Na+]: 527.2979, Found 
527.2985.  
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(2R, 6S)-2-Digitoxigenoxy-6-methyl-2H-pyran-3(6H)-one (31): 
O O
Me
OH
H
H
Me
H
OO
O
 
A CH2Cl2/THF solution (1.5 mL, 4:1 V/V) of Boc-pyranone 18α (316 mg, 1.39 mmol) 
and digitoxigenin (260 mg, 0.69 mmol) was cooled to 0 oC. A CH2Cl2 (0.24 mL) solution 
of Pd2(DBA)3•CHCl3 (17 mg, 2.5 mol%) and PPh3 (17 mg, 10 mol%) was added to the 
reaction mixture at 0 oC. The reaction mixture was stirred at 0 oC for 8 hours and was 
quenched with 4 mL of satd aq NaHCO3, extracted (3 x 10 mL) with Et2O, dried 
(Na2SO4), and concentrated under reduced pressure. The crude product was purified 
using silica gel flash chromatography eluting with 40% EtOAc/hexanes to give 31 (287 
mg, 0.59 mmol, 86%) as a white solid: Rf (40% EtOAc/hexanes) = 0.17; mp: 145-146 oC ; 
[α]25D= + 61.4 (c = 1.0, MeOH); IR (thin film, cm-1) 3481, 2939, 2253, 1738, 1698, 1620, 
1448, 1374, 1319, 1237, 1157, 1102, 1079, 1024, 958, 905, 859, 645; 1H NMR (600 MHz, 
CDCl3) δ 6.78 (dd, J = 10.4, 1.8 Hz, 1H), 5.99 (dd, J = 10.2, 1.2 Hz, 1H), 5.80 (m, 1H), 
5.21 (dd, J = 2.4, 1.8 Hz, 1H), 4.95 (dd, J = 18.0, 1.8 Hz, 1H), 4.50 (dd, J = 18.0, 1.8 Hz, 
1H), 4.04 (m, 2H), 2.73 (dd, J = 9.6, 6.0 Hz, 1H), 2.20-2.09 (m, 3H), 1.30 (d, J = 6.6 Hz, 
3H), 1.92-1.16 (m, 18H), 0.88 (s, 3H), 0.80 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 197.2, 
174.9, 174.6, 144.4, 126.7, 117.3, 91.9, 85.2, 75.2, 74.1, 73.4, 50.9, 49.6, 41.5, 40.0, 36.3, 
35.5, 35.0, 32.8, 30.3, 30.1, 26.8, 26.4, 26.3, 23.6, 21.2, 21.0, 15.6, 15.0; ESIHRMS 
Calcd for [C29H40O6Na+]: 507.2717,  Found 507.2722.  
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Digitoxigen 2,3-dideoxy-α-L-rhamno-hexopyranoside (27): 
O O
Me
OH
H
H
Me
H
OO
HO
 
A CH2Cl2 (1.4 mL) solution of enone 31 (287 mg, 0.59 mmol) and CeCl3 in MeOH 
solution (0.4 M, 1.4 mL) was cooled to -78 oC. NaBH4 (20 mg, 0.6 mmol) was added and 
the reaction mixture was stirred at -78oC for 3 h. The reaction mixture was diluted with 
ether (10 mL) and was quenched with 10 mL of satd. aq NaHCO3, extracted (3 x 10 mL) 
with Et2O, dried (Na2SO4), and concentrated under reduced pressure. The crude product 
was purified using silica gel flash chromatography eluting with 55% EtOAc/hexanes to 
give allylic alcohol 27 (239 mg, 0.49 mmol, 83%) as a white solid: Rf (60% 
EtOAc/hexanes) = 0.22; mp: 193-194 oC; IR (thin film, cm-1) 3448, 2933, 2871, 1780, 
1741, 1618, 1446, 1378, 1320, 1180, 1135, 1049, 1024, 1004, 958, 751; 1H NMR (600 
MHz, CDCl3) δ 5.90 (ddd, J = 10.2, 4.8, 1.2 Hz, 1H), 5.85 (m, 1H), 5.72 (d, J = 10.2 Hz, 
1H), 5.07 (m, 1H), 4.98 (dd, J = 18.0, 1.2 Hz, 1H), 4.80 (dd, J = 18.0, 1.8 Hz, 1H), 4.11 
(dd, J = 4.2, 1.8 Hz, 1H), 3.97 (s, 1H), 3.82 (qd, J = 6.6, 2.4Hz, 1H), 3.74 (br, 1H), 2.77 
(dd, J = 9.6, 6.0 Hz, 1H), 2.25-2.05 (m, 3H), 1.29 (d, J = 6.0 Hz, 3H), 1.80-1.05 (m, 18H), 
0.92 (s, 3H), 0.86 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 174.6, 132.8, 127.5, 117.6, 
93.2, 85.5, 73.6, 73.4, 69.7, 67.9, 64.9, 50.90, 49.5, 41.8, 40.0, 36.4, 35.7, 35.1, 33.1, 30.7, 
30.3, 26.7 (2C), 26.5, 23.6, 21.3, 21.1, 17.9, 15.7; ESIHRMS Calcd for [C29H42O6Na+]: 
509.2879,  Found 509.2879.  
 
 30
Digitoxigen α-L-rhamno-hexopyranoside (28): 
O O
Me
OH
H
H
Me
H
OO
HO
OH
OH
 
To a t-BuOH/acetone (4 mL) solution of alcohol 27 (1.80 g, 3.82 mmol) at 0 oC was 
added a solution of (50% w/v) of N-methyl morpholine N-oxide/water (2.4 mL).   
Crystalline OsO4 (9.6 mg, 1 mol %) was added and the reaction was stirred for 4 h. The 
reaction was quenched with adding EtOAc and satd. NaHCO3. The organic layer was 
separated and concentrated. The crude product was purified by a silica gel column using 
90% EtOAc/hexanes. Pure fractions were combined, concentrated, and crystallized from 
acetone/hexanes to afford triol 28 as a white solid (2.07 g, 3.55mmol, 93%): Rf (EtOAc) 
= 0.20; mp: 224-225 oC; [α]25D = -24.0 (c = 0.7, MeOH); IR (thin film, cm-1) 3453, 2925, 
2856, 1775, 1736, 1623, 1449, 1454, 1378, 1160, 1076, 1024, 951, 822; 1H NMR (600 
MHz, CDCl3) δ 5.87 (m, 1H), 4.98 (dd, J = 18.0, 1.2 Hz, 1H), 4.87 (m, 1H), 4.80 (dd, J = 
18.0, 1.2 Hz, 1H), 4.12 (ddd, J = 3.0, 3.0, 3.0 Hz, 1H), 4.06 (m, 1H), 3.71 (dq, J = 9.0, 
6.0 Hz, 1H), 3.44 (m, 1H), 2.77 (m, 1H), 2.58 (s, 1H), 2.36 (s, 1H) 2.20-2.00 (m, 4H), 
1.30 (d, J = 6.0 Hz, 3H), 1.90-1.10 (m, 19H), 0.93 (s, 3H), 0.87 (s, 3H); 13C NMR (150 
MHz, CDCl3) δ 174.48, 174.45, 117.8, 97.5, 85.6, 73.8, 73.4, 71.9, 71.6, 67.8, 50.9, 49.6, 
41.9, 40.1, 38.3, 36.4, 35.7, 35.2, 33.2, 30.3, 29.5, 26.6, 26.5, 26.4, 23.7, 21.4, 21.2, 17.5, 
15.8; ESIHRMS Calcd for [C29H44O8Na+]: 543.6446, Found 543.6446.  
 
 31
Digitoxigen 2,3-dideoxy-2,3-dihydro-α-L-rhamno-hexopyranoside (29): 
O O
Me
OH
H
H
Me
H
OO
HO
 
To a CH2Cl2 (0.35 mL) solution of allylic alcohol 27 (49 mg, 0.1 mmol) was added Et3N 
(50.6 mg, 0.5 mmol), o-nitrobenzenesulfonyl hydrazide (NBSH) (101.5 mg, 0.5 mmol). 
The reaction was stirred at room temperature for 6 h. The reaction mixture was diluted 
with ether (5 mL) and was quenched with satd. aq NaHCO3, extracted (3 x 10 mL) with 
Et2O, dried (Na2SO4), and concentrated under reduced pressure. The crude product was 
purified using silica gel flash chromatography eluting with 25% EtOAc/hexanes to give 
product 29 (47 mg, 0.096 mmol, 96%) as a white solid: Rf (50% EtOAc/hexanes) = 0.20; 
mp: 180-181 oC; [α]25D = -33.0 (c = 0.4, MeOH); IR (thin film, cm-1) 3441, 2933, 2246, 
1737, 1619, 1448, 1379, 1339, 1258, 1225, 1115, 1029, 990, 955, 906, 858, 824. 1H 
NMR (600 MHz, CDCl3) δ 5.86 (m, 1H),  4.98 (dd, J = 18.0, 1.2 Hz, 1H), 4.81 (m, 1H), 
4.80 (dd, J = 18.0, 1.8 Hz, 1H), 4.11 (dd, J = 4.2, 1.8 Hz, 1H), 3.90 (s, 1H), 3.63 (br, 1H), 
3.25 (m, 1H), 2.77 (dd, J = 9.6, 6.0 Hz, 1H), 2.25-2.05 (m, 3H), 1.48 (s, 1H), 1.20 (m, 
6H), 1.80-1.05 (m, 19H), 0.92 (s, 3H), 0.86 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 174.6, 
174.5, 117.6, 94.0, 85.5, 73.5, 72.3, 70.9, 69.6, 50.9, 49.6, 41.8, 40.0, 36.4, 35.7, 35.2, 
33.1, 30.5, 30.2, 29.8, 27.7, 26.9, 26.7 (2C), 23.7, 21.4, 21.1, 17.9, 15.7; ESIHRMS 
Calcd for [C29H44O6Na+]: 511.6458,  Found 511.6458.  
 
 32
(2S, 6R)-2-Digitoxigenoxy-6-methyl-2H-pyran-3(6H)-one (32): 
O O
Me
OH
H
H
Me
H
OO
O
 
A CH2Cl2/THF solution (3 mL, 4:1 V/V) of Boc-pyranone 13β (200 mg, 0.87 mmol) and 
digitoxigenin (657 mg, 1.75 mmol) was cooled to 0 oC. A CH2Cl2 (0.36 mL) solution of 
Pd2(DBA)3•CHCl3 (26.2 mg, 2.5 mol%) and PPh3 (26.2 mg, 10 mol%) was added to the 
reaction mixture at 0 oC. The reaction mixture was stirred at 0 oC for 8 hours and was 
quenched with 5 mL of satd. aq NaHCO3, extracted (3 x 10 mL) with Et2O, dried 
(Na2SO4), and concentrated under reduced pressure. The crude product was purified 
using silica gel flash chromatography eluting with 40% EtOAc/hexanes to give 32 (337 
mg, 0.69 mmol, 80%) as a white solid: Rf (55% EtOAc/hexanes) = 0.45; mp: 211-212 oC ; 
[α]25D = -27.0 (c = 1.0, MeOH); IR (thin film, cm-1) 3502, 2936, 2249, 1780, 1737, 1697, 
1620, 1447, 1373, 1338, 1318, 1235, 1156, 1103, 1078, 1023, 958, 909, 824, 754; 1H 
NMR (600 MHz, CDCl3) δ 6.80 (dd, J = 10.4, 1.8 Hz, 1H), 6.12 (dd, J = 10.2, 1.2 Hz, 
1H), 5.87 (m, 1H), 5.25 (dd, J = 2.4, 1.8 Hz, 1H), 4.99 (dd, J = 18.0, 1.8 Hz, 1H), 4.80 
(dd, J = 18.0, 1.8 Hz, 1H), 4.08 (m, 2H), 2.78 (dd, J = 9.6, 6.0 Hz, 1H), 2.20-2.09 (m, 
3H), 1.35 (d, J = 6.6 Hz, 3H), 1.92-1.16 (m, 18H), 0.91 (s, 3H), 0.85 (s, 3H); 13C NMR 
(150 MHz, CDCl3) δ 197.0, 174.4, 174.3, 147.7, 128.2, 117.8, 93.9, 85.6, 75.2, 73.4, 73.3, 
50.9, 49.6, 41.9, 40.0, 36.3, 35.8, 35.2, 33.2, 32.0, 30.0, 26.9, 26.4, 24.4, 23.7, 21.3, 21.2, 
17.0, 15.8; ESIHRMS Calcd for [C29H40O6Na+]: 507.2717,  Found 507.2722. 
 33
(2S, 6R)-2-(Digitoxigenoxy)-2,5-dihydro-6-methyl-2H-pyran-5-ol (33): 
O O
Me
OH
H
H
Me
H
OO
HO
 
A CH2Cl2 (1.12 mL) solution of enone 33 (270 mg, 0.55 mmol) and CeCl3 in MeOH 
solution (0.4 M, 1.12 mL) was cooled to -78 oC. NaBH4 (20.8 mg, 0.55 mmol) was added 
and the reaction mixture was stirred at -78 oC for 3 h. The reaction mixture was diluted 
with ether (10 mL) and was quenched with 5 mL of satd. aq NaHCO3, extracted (3 x 10 
mL) with Et2O, dried (Na2SO4), and concentrated under reduced pressure. The crude 
product was purified using silica gel flash chromatography eluting with 55% 
EtOAc/hexanes to give allylic alcohol 33 (238 mg, 0.49 mmol, 90%) as a white solid: Rf 
(60% EtOAc/hexanes) = 0.20; mp: 198-199 oC; IR (thin film, cm-1) 3327, 2939, 2871, 
1738, 1741, 1618, 1448, 1378, 1320, 1180, 1135, 1049, 1024, 958, 750; 1H NMR (600 
MHz, CDCl3) δ 5.90 (ddd, J = 10.2, 4.8, 1.2 Hz, 1H), 5.86 (m, 1H), 5.73 (d, J = 10.2 Hz, 
1H), 5.01 (m, 1H), 4.97 (dd, J = 18.0, 1.2 Hz, 1H), 4.81 (dd, J = 18.0, 1.8 Hz, 1H), 4.00 
(dd, J = 4.2, 1.8 Hz, 1H), 3.83 (s, 1H), 3.73 (qd, J = 6.6, 2.4 Hz, 1H), 3.70 (br, 1H), 2.77 
(dd, J = 9.6, 6.0 Hz, 1H), 2.25-2.05 (m, 3H), 1.29 (d, J = 6.0 Hz, 3H), 1.80-1.05 (m, 18H), 
0.93 (s, 3H), 0.87 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 174.5, 174.4, 144.3, 127.0, 
117.6, 91.6, 85.5, 73.76, 73.4, 70.3, 50.9, 49.6, 41.8, 40.0, 36.7, 35.6, 35.2, 33.1, 32.0, 
30.1, 26.8 (2C), 26.5, 24.7, 23.7, 21.25, 21.16, 15.7, 15.2; ESIHRMS Calcd for 
[C29H42O6Na+]: 509.2879,  Found 509.2879.  
 
 34
Digitoxigen 2,3-dideoxy-2,3-dihydro-α-D-rhamno-hexopyranoside (34): 
O O
Me
OH
H
H
Me
H
OO
HO
 
To a CH2Cl2 (0.35 mL) solution of allylic alcohol 33 (50 mg, 0.1 mmol) was added Et3N 
(50.6 mg, 0.5 mmol), o-nitrobenzenesulfonyl hydrazide (NBSH) (101.5 mg, 0.5 mmol). 
The reaction was stirred at room temperature for 6h. The reaction mixture was diluted 
with ether (5 mL) and was quenched with satd. aq NaHCO3, extracted (3 x 10 mL) with 
Et2O, dried (Na2SO4), and concentrated under reduced pressure. The crude product was 
purified using silica gel flash chromatography eluting with 25% EtOAc/hexanes to give 
product 29 (46.5 mg, 0.095 mmol, 95%) as a white solid: Rf (50% EtOAc/hexanes) = 
0.20; mp: 180-181 oC; [α]25D = -33.0 (c = 0.4, MeOH); IR (thin film, cm-1) 3434, 2932, 
2242, 1780, 1736, 1619, 1447, 1379, 1338, 1225, 1149, 1115, 1029, 989, 956, 908, 857, 
824; 1H NMR (600 MHz, CDCl3) δ 5.86 (m, 1H),  4.98 (dd, J = 18.0, 1.2 Hz, 1H), 4.81 
(m, 1H), 4.80 (dd, J = 18.0, 1.8 Hz, 1H), 4.00 (dd, J = 4.2, 1.8 Hz, 1H), 3.92 (s, 1H), 3.63 
(br, 1H), 3.25 (m, 1H), 2.77 (dd, J = 9.6, 6.0 Hz, 1H), 2.25-2.05 (m, 3H), 1.48 (s, 1H), 
1.20 (m, 6H), 1.80-1.05 (m, 19H), 0.93 (s, 3H), 0.87 (s, 3H); 13C NMR (150 MHz, CDCl3) 
δ 174.6, 174.5, 117.6, 93.9, 85.5, 73.5, 72.3, 70.7, 69.6, 50.9, 49.6, 41.9, 40.1, 36.7, 35.7, 
35.2, 33.1, 32.0, 30.2, 30.1, 27.7, 26.9, 26.7 (2C), 23.7, 21.4, 21.1, 17.9, 15.8; ESIHRMS 
Calcd for [C29H44O6Na+]: 511.6458,  Found 511.6458.  
 
 35
L-β-glycoside desacetoxy-oleandrin (36): 
Me
Me
O
O
O
OH
H
H
HO
OMe
HO
 
To a mixture of diol 25 (25 mg, 0.05 mmol) and silver (I) oxide (0.23 g, 1 mmol), was 
added 0.25 mL CH3I. The reaction suspension was stirred at rt for 3 days. The reaction 
mixture was then passed through a celite pad with 20 mL Et2O, concentrated under 
reduced pressure and purified using silica flash chromatography eluting with 50% 
EtOAc/hexanes to give product 36 (6.49 mg, 0.012 mmol, 25%) as a white solid: Rf (50% 
EtOAc/hexanes) = 0.20; mp: 185-186 oC; [α]25D = +43.0 (c = 0.45, MeOH); IR (thin film, 
cm-1) 3453, 2932, 2856, 2173, 1969, 1775, 1742, 1623, 1449, 1454, 1378, 1160, 1067, 
1024, 951, 822, 731; 1H NMR (600 MHz, CDCl3) δ 5.86 (m, 1H), 4.98 (dd, J = 18.0, 1.8 
Hz, 1H), 4.80 (dd, J = 18.0, 1.8 Hz, 1H), 4.53 (dd, J = 9.6, 1.8 Hz, 1H), 4.02 (m, 1H), 
3.58 (dq, J = 9.0, 6.0 Hz, 1H), 3.40 (s, 3H), 3.24 (m, 1H), 3.09 (m, 1H), 2.77 (m, 1H), 
2.33 (s, 1H), 2.20-2.00 (m, 4H), 1.26 (d, J = 6.0 Hz, 3H), 1.90-1.10 (m, 21H), 0.92 (s, 
3H), 0.86 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 174.5, 174.4, 117.7, 97.5, 85.6, 81.0, 
73.4, 72.9, 71.8, 71.6, 56.2, 50.9, 49.6, 41.8, 40.0, 39.3, 36.2, 35.7, 35.2, 33.2, 32.0, 29.9, 
26.9, 26.4, 24.4, 23.6, 21.2, 21.1, 17.8, 15.8; ESIHRMS Calcd for [C30H46O7Na+]: 
541.3141, Found 541.3141.  
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